Chen J, Zhang D, Yan W, Yang D, Shen B. Application of translational bioinformatics in the diagnostic and prognostic assessment of prostate cancer during the next-generation sequencing era. BioMed Research International. 2013;2013:901578. doi:10.1155/2013/901578.

Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, Pukkala E, Christensen K, Adami H-O, Holm NV, et al. Genetic contributions to prostate cancer risk: Findings from the Nordic Twin Study of Cancer. Cancer Epidemiology, Biomarkers & Prevention. 2014;23(11):2303–2310. doi:10.1158/1055-9965.EPI-13-0568.

Termini D, Hartogh DJD, Jaglanian A, Tsiani E. Curcumin as a potential therapeutic agent against prostate cancer: A review of current evidence. Biomolecules. 2020;10(11):1536. doi:10.3390/biom10111536.

Wen S, Chang H-C, Tian J, Shang Z, Niu Y, Chang C. Role of stromal androgen receptor in the development of normal prostate, benign prostatic hyperplasia, and prostate cancer. The American Journal of Pathology. 2015;185(2):293–301. doi:10.1016/j.ajpath.2014.10.012.

Cittadini A, Isidori AM, Salzano A. Impact of testosterone therapy on cardiovascular health: A comprehensive review. Cardiovascular Research. 2021;118(10):2039–2057. doi:10.1093/cvr/cvab241.

Bluemn EG, Nelson PS. The androgen receptor signaling pathway in prostate cancer progression. Current Opinion in Oncology. 2012;24(3):251–257. doi:10.1097/CCO.0b013e32835105b3.

Ziaran S, Novakova ZV, Böhmer D, Danišovič L. Biomarkers for prostate cancer detection and prognosis: Current perspectives. Neoplasma. 2015;62(5):683–691. doi:10.4149/neo_2015_082.

Takayama K-I. Essential roles of splicing factors in prostate cancer progression and androgen receptor signaling pathways. Biomolecules. 2019;9(4):131. doi:10.3390/biom9040131.

Bach C, Pisipati S, Daneshwar D, Wright M, Rowe E, Gillatt D, Persad R, Koupparis A. Surgical management of high-risk prostate cancer: Current status and future perspectives. Nature Reviews Urology. 2014;11(6):342–351. doi:10.1038/nrurol.2014.100.

Ziegler A, Koch A, Krockenberger K, Großhennig A. Advances in personalized medicine through DNA biomarkers: A systematic review. Quality of Life Research. 2012;131(10):1627–1638. doi:10.1007/s00439-012-1188-9.